Cargando…

Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study

BACKGROUND: Chemotherapy-induced alopecia (CIA), although generally reversible, is felt as extremely distressing by patients with breast cancer. A certified medical device (Capelli Naturali a Contatto(®)—CNC(®)) was produced to provide patients with a personalized scalp prosthesis, reproducing the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Petruzzi, Alessandra, Mancuso, Anna Maria, Alfieri, Sara, Esposito, Antonella, Infante, Gabriele, Miceli, Rosalba, Ospitali, Stefano, Ripamonti, Carla Ida, Borreani, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719124/
https://www.ncbi.nlm.nih.gov/pubmed/36463143
http://dx.doi.org/10.1186/s12905-022-02080-7
_version_ 1784843248463773696
author Petruzzi, Alessandra
Mancuso, Anna Maria
Alfieri, Sara
Esposito, Antonella
Infante, Gabriele
Miceli, Rosalba
Ospitali, Stefano
Ripamonti, Carla Ida
Borreani, Claudia
author_facet Petruzzi, Alessandra
Mancuso, Anna Maria
Alfieri, Sara
Esposito, Antonella
Infante, Gabriele
Miceli, Rosalba
Ospitali, Stefano
Ripamonti, Carla Ida
Borreani, Claudia
author_sort Petruzzi, Alessandra
collection PubMed
description BACKGROUND: Chemotherapy-induced alopecia (CIA), although generally reversible, is felt as extremely distressing by patients with breast cancer. A certified medical device (Capelli Naturali a Contatto(®)—CNC(®)) was produced to provide patients with a personalized scalp prosthesis, reproducing the patient’s original hair, resistant to any type of everyday or sporting activity, and hairdressing. AIMS: The present study aimed to evaluate the impact of the CNC(®) device on the patient’s perception of their body image, psychological wellbeing, satisfaction, strengths and weakness of the CNC(®) device. METHOD: A pilot study was carried out on 21 patients affected by CIA due to recurrent breast cancer. A mixed quantitative/qualitative method was used, including administering a questionnaire and a focus group. RESULTS: Based on the Body Image Scale, body image perception improved after 3 and 6 months using the device in the 20 patients who answered the questionnaire. No significant change over time emerged for the six dimensions investigated by the Italian version of the Psychological Well-Being Scale. The thematic analysis of the focus groups showed six themes: definition of the prosthetic device, acceptance of the proposal, experience with the conventional wig, strengths, weaknesses, economic issues. CONCLUSION: Compared to the previous experience of CIA and the standard wig, the use of the CNC(®) device improved everyday life and may be proposed to women undergoing chemotherapy and expecting alopecia to prevent discomfort, social embarrassment, and compromised body image. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-022-02080-7.
format Online
Article
Text
id pubmed-9719124
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97191242022-12-04 Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study Petruzzi, Alessandra Mancuso, Anna Maria Alfieri, Sara Esposito, Antonella Infante, Gabriele Miceli, Rosalba Ospitali, Stefano Ripamonti, Carla Ida Borreani, Claudia BMC Womens Health Research Article BACKGROUND: Chemotherapy-induced alopecia (CIA), although generally reversible, is felt as extremely distressing by patients with breast cancer. A certified medical device (Capelli Naturali a Contatto(®)—CNC(®)) was produced to provide patients with a personalized scalp prosthesis, reproducing the patient’s original hair, resistant to any type of everyday or sporting activity, and hairdressing. AIMS: The present study aimed to evaluate the impact of the CNC(®) device on the patient’s perception of their body image, psychological wellbeing, satisfaction, strengths and weakness of the CNC(®) device. METHOD: A pilot study was carried out on 21 patients affected by CIA due to recurrent breast cancer. A mixed quantitative/qualitative method was used, including administering a questionnaire and a focus group. RESULTS: Based on the Body Image Scale, body image perception improved after 3 and 6 months using the device in the 20 patients who answered the questionnaire. No significant change over time emerged for the six dimensions investigated by the Italian version of the Psychological Well-Being Scale. The thematic analysis of the focus groups showed six themes: definition of the prosthetic device, acceptance of the proposal, experience with the conventional wig, strengths, weaknesses, economic issues. CONCLUSION: Compared to the previous experience of CIA and the standard wig, the use of the CNC(®) device improved everyday life and may be proposed to women undergoing chemotherapy and expecting alopecia to prevent discomfort, social embarrassment, and compromised body image. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-022-02080-7. BioMed Central 2022-12-03 /pmc/articles/PMC9719124/ /pubmed/36463143 http://dx.doi.org/10.1186/s12905-022-02080-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Petruzzi, Alessandra
Mancuso, Anna Maria
Alfieri, Sara
Esposito, Antonella
Infante, Gabriele
Miceli, Rosalba
Ospitali, Stefano
Ripamonti, Carla Ida
Borreani, Claudia
Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study
title Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study
title_full Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study
title_fullStr Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study
title_full_unstemmed Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study
title_short Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study
title_sort evaluation of the cnc(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719124/
https://www.ncbi.nlm.nih.gov/pubmed/36463143
http://dx.doi.org/10.1186/s12905-022-02080-7
work_keys_str_mv AT petruzzialessandra evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy
AT mancusoannamaria evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy
AT alfierisara evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy
AT espositoantonella evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy
AT infantegabriele evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy
AT micelirosalba evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy
AT ospitalistefano evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy
AT ripamonticarlaida evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy
AT borreaniclaudia evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy